HTBX — Stock activity · TradeandTellHTBX
HTBX
$2.38+$0.01 (+0.42%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
Held by traders on TradeandTell
No one on the platform currently holds HTBX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HTBX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|
| 2020-12-11 | 1-for-7reverse |
| 2018-01-22 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded HTBX yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Earnings surprises
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2022-05-16 | $-0.49 | $-0.32 | +33.7% |
| 2022-03-11 | $-0.32 | $-0.54 | -68.8% |
| 2021-11-10 | $-0.30 | $-0.30 | +0.0% |
| 2021-08-11 | $-0.30 | $-0.26 | +13.3% |
| 2021-05-05 | $-0.29 | $-0.31 | -6.9% |
| 2021-03-25 | $-0.35 | $-0.02 | +94.3% |
| 2020-11-09 | $-0.23 | $-0.42 | -82.6% |
| 2020-08-07 | $-0.66 | $-0.35 | +47.0% |
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| HTBXHeat Biologics, Inc. | $2.38 | +0.42% | $61M | — |
| ACHLAchilles Therapeutics plc | $1.48 | +0.68% | $61M | — |
| ALVRAlloVir, Inc. | $9.81 | +4.14% | $49M | — |
| HYFTMindWalk Holdings Corp. | $1.39 | +0.84% | $65M | — |
| KRONKronos Bio, Inc. | $0.88 | +1.49% |
| QNCXQuince Therapeutics, Inc. | $34.10 | +5.21% | $9M | — |
| RPHMReneo Pharmaceuticals, Inc. | $18.20 | +952.02% | $61M | — |
Source: Financial Modeling Prep · peers by sector/industry